SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-072919
Filing Date
2024-03-20
Accepted
2024-03-20 18:08:58
Documents
2
Group Members
HEALTHCAP VII GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d805091dsc13da.htm SC 13D/A 44808
2 EX-99.5 d805091dex995.htm EX-99.5 56569
  Complete submission text file 0001193125-24-072919.txt   102975
Mailing Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018
Business Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018 41 21 614 3500
HealthCap VII, L.P. (Filed by) CIK: 0001645161 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Subject) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91552 | Film No.: 24768881
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)